FIGURE 1 TABLE 1 The detail mechanisms of flavonoids for the treatment of epilepsy
Tirzepatide, initially approved by the FDA to treat diabetes, works through a dual-targeted treatment mechanism that influences insulin production and slows digestion, leading to reduced food intake and better control of blood sugar levels
The common yet unverified belief is that the demand for MedTech products might decrease due to these therapies' positive effects on obesity-related conditions
Reddy's Laboratories, a powerhouse in generic drugs, which started manufacturing semaglutide for export after obtaining a license in December 2024
These topics can be included, but they should be presented with clear, evidence-aware language
Trials funded by Novo Nordisk have shown a mean weight loss of up to 15% from oral semaglutide in adults without diabetes